BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu J, Inomata T, Fujimoto K, Uchida K, Fujio K, Nagino K, Miura M, Negishi N, Okumura Y, Akasaki Y, Hirosawa K, Kuwahara M, Eguchi A, Shokirova H, Yanagawa A, Midorikawa-Inomata A, Murakami A. Ex Vivo-Induced Bone Marrow-Derived Myeloid Suppressor Cells Prevent Corneal Allograft Rejection in Mice. Invest Ophthalmol Vis Sci 2021;62:3. [PMID: 34061951 DOI: 10.1167/iovs.62.7.3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Okumura Y, Inomata T, Fujimoto K, Fujio K, Zhu J, Yanagawa A, Shokirova H, Saita Y, Kobayashi Y, Nagao M, Nishio H, Sung J, Midorikawa-Inomata A, Eguchi A, Nagino K, Akasaki Y, Hirosawa K, Huang T, Kuwahara M, Murakami A. Biological effects of stored platelet-rich plasmaeye-drops in corneal wound healing. Br J Ophthalmol 2022:bjo-2022-322068. [PMID: 36162968 DOI: 10.1136/bjo-2022-322068] [Reference Citation Analysis]
2 Fujio K, Sung J, Nakatani S, Yamamoto K, Iwagami M, Fujimoto K, Shokirova H, Okumura Y, Akasaki Y, Nagino K, Midorikawa-inomata A, Hirosawa K, Miura M, Huang T, Morooka Y, Kuwahara M, Murakami A, Inomata T. Characteristics and Clinical Ocular Manifestations in Patients with Acute Corneal Graft Rejection after Receiving the COVID-19 Vaccine: A Systematic Review. JCM 2022;11:4500. [DOI: 10.3390/jcm11154500] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Liu R, Yi R, Chen X, Yi G, Fu M. Lentivirus-mediated PD-L1 overexpression in bone marrow-derived dendritic cells induces immune tolerance in a rat keratoplasty model. Transpl Immunol 2022;74:101654. [PMID: 35777615 DOI: 10.1016/j.trim.2022.101654] [Reference Citation Analysis]
4 Zhu J, Inomata T, Nakamura M, Fujimoto K, Akasaki Y, Fujio K, Yanagawa A, Uchida K, Sung J, Negishi N, Nagino K, Okumura Y, Miura M, Shokirova H, Kuwahara M, Hirosawa K, Midorikawa-Inomata A, Eguchi A, Huang T, Yagita H, Habu S, Okumura K, Murakami A. Anti-CD80/86 antibodies inhibit inflammatory reaction and improve graft survival in a high-risk murine corneal transplantation rejection model. Sci Rep 2022;12:4853. [PMID: 35318419 DOI: 10.1038/s41598-022-08949-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhu J, Inomata T, Di Zazzo A, Kitazawa K, Okumura Y, Coassin M, Surico PL, Fujio K, Yanagawa A, Miura M, Akasaki Y, Fujimoto K, Nagino K, Midorikawa-Inomata A, Hirosawa K, Kuwahara M, Huang T, Shokirova H, Eguchi A, Murakami A. Role of Immune Cell Diversity and Heterogeneity in Corneal Graft Survival: A Systematic Review and Meta-Analysis. J Clin Med 2021;10:4667. [PMID: 34682792 DOI: 10.3390/jcm10204667] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Inomata T, Sung J, Nakamura M, Iwagami M, Okumura Y, Fujio K, Akasaki Y, Fujimoto K, Yanagawa A, Midorikawa-inomata A, Nagino K, Eguchi A, Shokirova H, Zhu J, Miura M, Kuwahara M, Hirosawa K, Huang T, Morooka Y, Murakami A. Cross-hierarchical Integrative Research Network for Heterogenetic Eye Disease Toward P4 Medicine: A Narrative Review. Juntendo Medical Journal 2021;67:519-29. [DOI: 10.14789/jmj.jmj21-0023-r] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]